Eli Lilly and Co at Guggenheim Healthcare Talks Idea Forum and Oncology Day Transcript
All right. Thanks, everybody. I'm Seamus Fernandez, the large pharma analyst here at Guggenheim Securities. This is our second annual Oncology Day, and I'm really pleased to be joined by Eli Lilly. We have a number of members of the team here and in the audience. Up on stage here with us on the far left are -- is Dr. Maura Dickler. Dr. Dickler is Vice President of the Late-Phase Oncology Development Opportunities. We also have Eric Dozier, who's the Vice President of Oncology, North America. And beside him, I think many of you know Jake Van Naarden, who is the Chief Operating Officer of Loxo Oncology and joined Lilly, I think, a little over a year ago with the acquisition of Loxo Oncology. So with that, thank you all for joining us.
Questions & Answers
There's a lot going on at Lilly Oncology. I guess for starters,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
